Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
暂无分享,去创建一个
Qiang Yang | Ping Guo | Miao Chen | Liren Li | Ranran Tang | Changlin Zhang | L. Qin | P. Zhou | Wei Guo | Wendan Yu | Jiaojiao Hao | Wuguo Deng | Tianhua Zhu | L. Zou | Manyu Chen | Kui Jiang | Jingshu Wang | G. Qin | Qian Long | Yizhuo Li | W. Fan | Sheng Hu | Xiuping Zhang | Chunfang Tian | Chaoliang Diao | Yandong Ren | Wen-hua Fan
[1] Xiaojing Xu,et al. Carbohydrate-based adjuvants activate tumor-specific Th1 and CD8+ T-cell responses and reduce the immunosuppressive activity of MDSCs. , 2019, Cancer letters.
[2] T. Billiar,et al. iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway , 2018, Proceedings of the National Academy of Sciences of the United States of America.
[3] Sung-Hoon Kim,et al. Melatonin disturbs SUMOylation‐mediated crosstalk between c‐Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells , 2018, Journal of pineal research.
[4] N. Osman,et al. Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma , 2017, International journal of molecular sciences.
[5] Dawei Xu,et al. WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells. , 2017, Cancer research.
[6] J. Kirkwood,et al. Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma , 2017, Scientific Reports.
[7] P. Ott,et al. Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma , 2017, Cancer and Metastasis Reviews.
[8] Quentin Liu,et al. Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells. , 2017, American Journal of Cancer Research.
[9] M. Wick,et al. Metastatic melanoma: Pathologic characterization, current treatment, and complications of therapy. , 2016, Seminars in diagnostic pathology.
[10] Wenlin Huang,et al. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells , 2015, Oncotarget.
[11] M. Schumacher,et al. The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration , 2015, Neuroscience.
[12] A. Gasbarrini,et al. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour‐initiating properties of colon cancer stem cells , 2015, The Journal of pathology.
[13] A. Rotte,et al. Immunotherapy of melanoma: Present options and future promises , 2015, Cancer and Metastasis Reviews.
[14] S. Leyvraz,et al. High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells , 2014, PloS one.
[15] Hemant R. Jadhav,et al. Melatonin: functions and ligands. , 2014, Drug discovery today.
[16] Sung-Hoon Kim,et al. Melatonin Sensitizes H1975 Non-Small-Cell Lung Cancer Cells Harboring a T790M-Targeted Epidermal Growth Factor Receptor Mutation to the Tyrosine Kinase Inhibitor Gefitinib , 2014, Cellular Physiology and Biochemistry.
[17] Tack-Joong Kim,et al. Melatonin Combined with Endoplasmic Reticulum Stress Induces Cell Death via the PI3K/Akt/mTOR Pathway in B16F10 Melanoma Cells , 2014, PloS one.
[18] Xiao-yi Qi,et al. Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma , 2013, IUBMB life.
[19] C. Alonso-González,et al. Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells , 2013, Journal of pineal research.
[20] Wenlin Huang,et al. Melatonin potentiates the antiproliferative and pro‐apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways , 2013, Journal of pineal research.
[21] Jian Huang,et al. Cancer stem cell theory: therapeutic implications for nanomedicine , 2013, International journal of nanomedicine.
[22] R. Reiter,et al. Melatonin membrane receptors in peripheral tissues: Distribution and functions , 2012, Molecular and Cellular Endocrinology.
[23] T. Gilmer,et al. Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations , 2012, Molecular Cancer Therapeutics.
[24] S. Kopetz,et al. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. , 2012, Cancer research.
[25] Nikhil Wagle,et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[27] H. Moch,et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. , 2011, Cancer research.
[28] J. Engelman,et al. Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers , 2011, Oncotarget.
[29] J. Till,et al. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. 1961. , 2011, Radiation research.
[30] B. Taylor,et al. The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner , 2010, Proceedings of the National Academy of Sciences.
[31] Irving L. Weissman,et al. Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271 , 2010, Nature.
[32] R. Reiter,et al. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK‐MEL‐1 cells , 2010, Journal of pineal research.
[33] Chao Zhang,et al. RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF , 2010, Nature.
[34] E. Grimm,et al. NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma. , 2009, The Journal of investigative dermatology.
[35] Gideon Rechavi,et al. MDR1 expression identifies human melanoma stem cells. , 2008, Biochemical and biophysical research communications.
[36] Michael F Clarke,et al. The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.
[37] N. Ahmad,et al. Melatonin in cancer management: progress and promise. , 2006, Cancer research.
[38] L. Broemeling,et al. Tumor iNOS predicts poor survival for stage III melanoma patients , 2006, International journal of cancer.
[39] R. Reiter,et al. RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line. , 2004, Cancer letters.
[40] D. Barford,et al. Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.
[41] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[42] C. Peyssonnaux,et al. The Raf/MEK/ERK pathway: new concepts of activation , 2001, Biology of the cell.
[43] J. Barrett,et al. The oncostatic action of melatonin in an ovarian carcinoma cell line , 1999, Journal of pineal research.
[44] A. Miles,et al. Melatonin and psychiatry , 1988, Biological Psychiatry.
[45] G. Maestroni,et al. Role of the pineal gland in immunity Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone , 1986, Journal of Neuroimmunology.
[46] Y. Grinevich,et al. Melatonin, Thymic Serum Factor, and Cortisol Levels in Healthy Subjects of Different Age and Patients With Skin Melanoma , 1986, Journal of pineal research.
[47] L. Wetterberg,et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome , 1985, Acta psychiatrica Scandinavica.
[48] A. N. Taylor,et al. Indole Compounds: Isolation from Pineal Tissue , 1965, Science.
[49] J. Till,et al. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.